Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03998475
Other study ID # HM20015399
Secondary ID 1-19-PDF-041-R
Status Completed
Phase N/A
First received
Last updated
Start date July 11, 2019
Est. completion date September 16, 2020

Study information

Verified date November 2020
Source Virginia Commonwealth University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this research study is to find out more about how to support young adults (ages 18-22) with type 1 diabetes as they prepare to transition from pediatric and adult endocrinology medical care.


Description:

The overarching goal of the proposed trial is to improve diabetes self-management and glycemic control in young adults and prepare them for the transition to adult endocrinology. The current application will investigate the impact of a multisystem transition preparation intervention for young adults (ages 18-22) with T1D. Twenty-five young adults and a parent will be enrolled in a 6-month transition preparation program which will use a hybrid in-person and technology delivery structure. Providers will receive training highlighting their role preparing young adults for transition and provides practical tips to use in their communication with young adults. If effective, this multisystem intervention, designed to enhance T1D self-management and increase young adults' readiness for transition to adult healthcare during this critical developmental period, has the potential to inform clinical practice guidelines.


Recruitment information / eligibility

Status Completed
Enrollment 62
Est. completion date September 16, 2020
Est. primary completion date September 16, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: Both members of the youth/parent dyad must meet all eligibility criteria Young adults - English-speaking - patients in Pediatric Endocrinology at Children's Hospital of Richmond (CHoR) at Virginia Commonwealth University (VCU) - between ages 18-22 yrs with a - diagnosis of T1D for >1 year Parents - greater than 18 years of age - provide care to the young adult with T1D - are willing to participate in the intervention Medical providers • provide care to patients with T1D ages 18-22 yrs in Pediatric Endocrinology at CHoR Exclusion Criteria: Young adults - significant psychiatric, cognitive, medical or developmental conditions that would impair their ability to complete assessments and/or engage in diabetes self-care behaviors (e.g., malignancies, psychosis, intellectual disability), as documented in the medical record or revealed during eligibility screening, or - medically-induced diabetes or diagnosis of diabetes other than type 1 diabetes Parents - non-English speaking - psychiatric, cognitive, or developmental conditions that would impair their ability to complete assessments and/or engage in the intervention as determined at study screening

Study Design


Intervention

Behavioral:
Transition preparation intervention
Young adult participants and parents will complete transition preparation sessions that include meeting with a health behavior coach for in-person sessions and review of materials sent electronically between study visits.

Locations

Country Name City State
United States Children's Hospital of Richmond at Virginia Commonwealth University Richmond Virginia

Sponsors (2)

Lead Sponsor Collaborator
Virginia Commonwealth University American Diabetes Association

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Change in diabetes self-efficacy Participant (young adult) report on the Self-Efficacy for Diabetes Self-Management (SEDSM) Baseline to 9 months
Other Change in diabetes quality of life Participant (young adult) report on the Pediatric Quality of Life Diabetes Module Baseline to 9 months
Other Change in diabetes family responsibility Average of young adult and parent participant reports on the Diabetes Family Responsibility Questionnaire (DFRQ) Baseline to 9 months
Other Change in diabetes family conflict Average of young adult and parent participant reports on the Diabetes Family Conflict Scale (DFCS) Baseline to 9 months
Other Change in depression Participant (young adult) report on the Center for Epidemiologic Studies Depression Scale (CESD) Baseline to 9 months
Other Change in young adult diabetes distress Participant (young adult) report on the Diabetes Distress Scale Baseline to 9 months
Other Change in parent diabetes distress Participant (parent) report on the Diabetes Distress Scale for Parents of Teens with T1D Baseline to 9 months
Other Change in autonomy support Participant (young adult) report on the autonomy support sub-scale of the Barriers to Diabetes Adherence Questionnaire Baseline to 9 months
Other Change in problem solving Participant (young adult) report on the Diabetes Adherence Problem Solving Questionnaire Baseline to 9 months
Primary Number of sessions attended Number of study visits (attendance) 6 months
Primary Number of session views Number of opened electronic materials (e.g., opened messages in the patient health portal)) 6 months
Primary Program acceptability - young adult Young adult report on satisfaction with the program via an exit survey 9 months
Primary Program acceptability - parent Parent report on satisfaction with the program via an exit survey 9 months
Primary Program acceptability - provider Provider report on satisfaction with the program via an exit survey 9 months
Secondary Change in Glycemic control Measurement of hemoglobin A1c (A1c; reported as a percentage) Baseline to 9 months
Secondary Diabetes-related hospitalizations Participant report and medical record review of count of reported diabetes-related hospitalizations and complications 9 months
Secondary Change in adherence to diabetes care regimen Average of young adult and parent participant reports on the Diabetes Management Questionnaire (DMQ) Baseline to 9 months
Secondary Change in transition readiness Average of young adult and parent participant reports on the Transition Readiness Assessment Questionnaire (TRAQ) Baseline to 9 months
See also
  Status Clinical Trial Phase
Recruiting NCT05653518 - Artificial Pancreas Technology to Reduce Glycemic Variability and Improve Cardiovascular Health in Type 1 Diabetes N/A
Enrolling by invitation NCT05515939 - Evaluating the InPen in Pediatric Type 1 Diabetes
Completed NCT05109520 - Evaluation of Glycemic Control and Quality of Life in Adults With Type 1 Diabetes During Continuous Glucose Monitoring When Switching to Insulin Glargine 300 U/mL
Recruiting NCT04016987 - Automated Structured Education Based on an App and AI in Chinese Patients With Type 1 Diabetes N/A
Active, not recruiting NCT04190368 - Team Clinic: Virtual Expansion of an Innovative Multi-Disciplinary Care Model for Adolescents and Young Adults With Type 1 Diabetes N/A
Recruiting NCT05413005 - Efficacy of Extracorporeal Photopheresis (ECP) in the Treatment of Type 1 Diabetes Mellitus Early Phase 1
Active, not recruiting NCT04668612 - Dual-wave Boluses in Children With Type 1 Diabetes Insulin Boluses in Children With Type 1 Diabetes N/A
Completed NCT02837094 - Enhanced Epidermal Antigen Specific Immunotherapy Trial -1 Phase 1
Recruiting NCT05414409 - The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action Phase 2
Recruiting NCT05670366 - The Integration of Physical Activity Into the Clinical Decision Process of People With Type 1 Diabetes N/A
Active, not recruiting NCT05418699 - Real-life Data From Diabetic Patients on Closed-loop Pumps
Completed NCT04084171 - Safety of Artificial Pancreas Therapy in Preschoolers, Age 2-6 N/A
Recruiting NCT06144554 - Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes
Recruiting NCT05153070 - Ciclosporin Followed by Low-dose IL-2 in Patients With Recently Diagnosed Type 1 Diabetes Phase 2
Recruiting NCT05379686 - Low-Dose Glucagon and Advanced Hybrid Closed-Loop System for Prevention of Exercise-Induced Hypoglycaemia in People With Type 1 Diabetes N/A
Completed NCT05281614 - Immune Effects of Vedolizumab With or Without Anti-TNF Pre-treatment in T1D Early Phase 1
Withdrawn NCT04259775 - Guided User-initiated Insulin Dose Enhancements (GUIDE) to Improve Outcomes for Youth With Type 1 Diabetes N/A
Active, not recruiting NCT01600924 - Study on the Assessment of Determinants of Muscle and Bone Strength Abnormalities in Diabetes
Completed NCT02750527 - Pediatric Population Screening for Type 1 Diabetes and Familial Hypercholesterolemia in Lower Saxony, Germany
Completed NCT02897557 - Insulet Artificial Pancreas Early Feasibility Study N/A